 to the editor re comparing prescription drugs editorial aug 27 the food and drug administration is allowed only to require manufacturers to prove safety and efficacy before approving any new drug to make rational decisions we need additional information including comparative effectiveness versus currently available medications and cost effectiveness our inability to make comparisons not only impedes doctors and patients who want to make informed choices but it is also a major obstacle to the introduction of important health policy reforms like the prescription drug benefit being considered without a rational basis for determining coverage how can taxpayers be assured that the money made available will be used wisely you call for federal financing initiatives to remedy the situation this should be matched with a requirement that the manufacturers themselves support this research alvin i mushlin md new york aug 28 2003 the writer is chairman department of public health weill cornell medical center

